Table 2.
Bipolar Spectrum Disorder |
Psychotic Disorder |
|||||
---|---|---|---|---|---|---|
Phase I (62 Families) | Phase I + II (154 Families) | Familial Casesa (99 Families) | Phase I (57 Families) | Phase I + II (144 Families) | Familial Casesa (102 Families) | |
DAOA | ||||||
rs3916966 | .696 | .966 | .906 | .843 | .839 | .616 |
rs2391191 | .889 | .913 | .735 | .87 | .891 | .349 |
rs2153674 | .072 | .353 | .095 | .066 | .700 | .233 |
rs701567 | .670 | .593 | .407 | .278 | .133 | .031 |
rs778326 | .025 | .111 | .024 | .010 | .186 | .018 |
rs954580 | .040 | .107 | .052 | .049 | .565 | .252 |
COMT | ||||||
rs4680 | .085 | .046 | .020 | .340 | .072 | .149 |
rs165599 | .003 | .829 | .035 | .015 | .396 | .103 |
COMT, catechol-O-methyl transferase; DAOA, d-amino acid oxidase activator; HRR, haplotype relative risk; SNP, single nucleoide polymorphism.
Familial cases include only families that contain at least two affected individuals.